Advertisement

Osteolytic Enzymes of Osteoclasts

  • Merry Jo Oursler
Chapter
Part of the Topics in Bone Biology book series (TBB, volume 2)

Keywords

Bone Resorption Giant Cell Tumor Osteoclastic Bone Resorption Bone Resorp Purple Acid Phosphatase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Agnihotri R, Crawford HC, Haro H, Matrisian LM, Havrda MC, Liaw L (2001) Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem 276:28261–7.CrossRefPubMedGoogle Scholar
  2. 2.
    Aimes RT, Quigley JP (1995) Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3/4-and 1/4-length fragments. J Biol Chem 270:5872–6.PubMedGoogle Scholar
  3. 3.
    Andersson G, Ek-Rylander B, Hollberg K, Ljusberg-Sjolander J, Lang P, Norgard M, et al. (2003) TRACP as an osteopontin phosphatase. J Bone Miner Res 18:1912–15.PubMedGoogle Scholar
  4. 4.
    Baron R, Neff L, Louvard D, Courtoy PJ (1985) Cellmediated extracellular acidification and bone resorption: Evidence for a low pH in resorbing lacunae and localization of a 100-kDa lysosomal membrane protein at the osteoclast ruffled border. J Cell Biol 101:2210–22.CrossRefPubMedGoogle Scholar
  5. 5.
    Becker JW, Marcy AI, Rokosz LL, Axel MG, Burbaum JJ, Fitzgerald PM, et al. (1995) Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme. Protein Sci 4:1966–76.PubMedCrossRefGoogle Scholar
  6. 6.
    Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, et al. (1993) Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 4:197–250.PubMedGoogle Scholar
  7. 7.
    Bord S, Horner A, Beeton CA, Hembry RM, Compston JE (1999) Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone. Bone 24:229–35.CrossRefPubMedGoogle Scholar
  8. 8.
    Bord S, Horner A, Hembry RM, Reynolds JJ, Compston JE (1997) Distribution of matrix metalloproteinases and their inhibitor, TIMP-1, in developing human osteophytic bone. J Anat 191(Pt 1):39–48.CrossRefPubMedGoogle Scholar
  9. 9.
    Bossard MJ, Tomaszek TA, Thompson SK, Amegadzie BY, Hanning CR, Jones C, et al. (1996) Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem 271:12517–24.PubMedGoogle Scholar
  10. 10.
    Brubaker KD, Vessella RL, True LD, Thomas R, Corey E (2003) Cathepsin K mRNA and protein expression in prostate cancer progression. J Bone Miner Res 18:222–30.PubMedGoogle Scholar
  11. 11.
    Buhling F, Reisenauer A, Gerber A, Kruger S, Weber E, Bromme D, et al. (2001) Cathepsin K — a marker of macrophage differentiation? J Pathol 195:375–82.PubMedGoogle Scholar
  12. 12.
    Buhling F, Waldburg N, Gerber A, Hackel C, Kruger S, Reinhold D, et al. (2000) Cathepsin K expression in human lung. Adv Exp Med Biol 477:281–6.PubMedGoogle Scholar
  13. 13.
    Chellaiah MA, Hruska KA (2003) The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue Int 72:197–205.CrossRefPubMedGoogle Scholar
  14. 14.
    Chellaiah MA, Kizer N, Biswas R, Alvarez U, Strauss-Schoenberger J, Rifas L, et al. (2003) Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression. Mol Biol Cell 14:173–89.CrossRefPubMedGoogle Scholar
  15. 15.
    Chiellini C, Costa M, Novelli SE, Amri EZ, Benzi L, Bertacca A, et al. (2003) Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. J Cell Physiol 195:309–21.CrossRefPubMedGoogle Scholar
  16. 16.
    Delaisse JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L (2003) Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61:504–13.PubMedGoogle Scholar
  17. 17.
    Delaisse JM, Boyde A, Maconnachie E, Ali NN, Sear CH, Eeckhout Y, et al. (1987) The effects of inhibitors of cysteine-proteinases and collagenase on the resorptive activity of isolated osteoclasts. Bone 8:305–13.PubMedGoogle Scholar
  18. 18.
    Delaisse JM, Eeckhout Y, Sear C, Galloway A, McCullagh K, Vaes G (1985) A new synthetic inhibitor of mammalian tissue collagenase inhibits bone resorption in culture. Biochem Biophys Res Commun 133:483–90.CrossRefPubMedGoogle Scholar
  19. 19.
    Delaisse JM, Eeckhout Y, Vaes G (1980) Inhibition of bone resorption in culture by inhibitors of thiol proteinases. Biochem J 192:365–8.PubMedGoogle Scholar
  20. 20.
    Delaisse JM, Eeckhout Y, Vaes G (1984) In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption. Biochem Biophys Res Commun 125:441–7.CrossRefPubMedGoogle Scholar
  21. 21.
    Delaisse JM, Eeckhout Y, Vaes G (1985) Bisphosphonates and bone resorption: effects on collagenase and lysosomal enzyme excretion. Life Sci 37:2291–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Delaisse JM, Ledent P, Vaes G (1991) Collagenolytic cysteine proteinases of bone tissue. Cathepsin B, (pro)cathepsin L and a cathepsin L-like 70kDa proteinase. Biochem J 279(Pt 1):167–74.PubMedGoogle Scholar
  23. 23.
    Dew G, Murphy G, Stanton H, Vallon R, Angel P, Reynolds JJ, et al. (2000) Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone. Cell Tissue Res 299:385–94.PubMedGoogle Scholar
  24. 24.
    Dhanaraj V, Ye QZ, Johnson LL, Hupe DJ, Ortwine DF, Dunbar JB, Jr., et al. (1996) X-ray structure of a hydroxamate inhibitor complex of stromelysin catalytic domain and its comparison with members of the zinc metalloproteinase superfamily. Structure 4:375–86.CrossRefPubMedGoogle Scholar
  25. 25.
    Diaz A, Willis AC, Sim RB (2000) Expression of the proteinase specialized in bone resorption, cathepsin K, in granulomatous inflammation. Mol Med 6:648–59.PubMedGoogle Scholar
  26. 26.
    Diaz A, Willis AC, Sim RB (2002) Cathepsin K expression in epithelioid and multinucleated giant cells. J Pathol 197:690; author reply 691.PubMedGoogle Scholar
  27. 27.
    Dodds RA, James IE, Rieman D, Ahern R, Hwang SM, Connor JR, et al. (2001) Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption. J Bone Miner Res 16:478–86.PubMedGoogle Scholar
  28. 28.
    Drake FH, Dodds RA, James IE, Connor JR, Debouck C, Richardson S, et al. (1996) Cathepsin K, but not cathepsins B, L, or S is abundantly expressed in human osteoclasts. Journal of Biological Chemistry 271:12511–16.PubMedGoogle Scholar
  29. 29.
    Ducsay CA, Buhi WC, Bazer FW, Roberts RM, Combs GE (1984) Role of uteroferrin in placental iron transport: effect of maternal iron treatment on fetal iron and uteroferrin content and neonatal hemoglobin. J Anim Sci 59:1303–8.PubMedGoogle Scholar
  30. 30.
    Ek-Rylander B, Flores M, Wendel M, Heinegard D, Andersson G (1994) Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 269:14853–6.PubMedGoogle Scholar
  31. 31.
    Elkins PA, Ho YS, Smith WW, Janson CA, D’Alessio KJ, McQueney MS, et al. (2002) Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase. Acta Crystallogr D Biol Crystallogr 58:1182–92.CrossRefPubMedGoogle Scholar
  32. 32.
    Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, et al. (2000) Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151:879–89.CrossRefPubMedGoogle Scholar
  33. 33.
    Etherington DJ, Birkedahl-Hansen H (1987) The influence of dissolved calcium salts on the degradation of hard-tissue collagens by lysosomal cathepsins. Coll Relat Res 7:185–99.PubMedGoogle Scholar
  34. 34.
    Everts V, Delaisse JM, Korper W, Beertsen W (1998) Cysteine proteinases and matrix metalloproteinases play distinct roles in the subosteoclastic resorption zone. J Bone Miner Res 13:1420–30.PubMedGoogle Scholar
  35. 35.
    Everts V, Delaisse JM, Korper W, Jansen DC, Tigchelaar-Gutter W, Saftig P, et al. (2002) The bone lining cell: its role in cleaning Howship’s lacunae and initiating bone formation. J Bone Miner Res 17:77–90.PubMedGoogle Scholar
  36. 36.
    Everts V, Delaisse JM, Korper W, Niehof A, Vaes G, Beertsen W (1992) Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J Cell Physiol 150:221–31.CrossRefPubMedGoogle Scholar
  37. 37.
    Everts V, Hou WS, Rialland X, Tigchelaar W, Saftig P, Bromme D, et al. (2003) Cathepsin K Deficiency in Pycnodysostosis Results in Accumulation of Non-Digested Phagocytosed Collagen in Fibroblasts. Calcif Tissue Int 73:380–86.CrossRefPubMedGoogle Scholar
  38. 38.
    Everts V, Korper W, Jansen DC, Steinfort J, Lammerse I, Heera S, et al. (1999) Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. Faseb J 13:1219–30.PubMedGoogle Scholar
  39. 39.
    Faccio R, Grano M, Colucci S, Zallone AZ, Quaranta V, Pelletier AJ (1998) Activation of alphav beta3 integrin on human osteoclast-like cells stimulates adhesion and migration in response to osteopontin. Biochem Biophys Res Commun 249:522–5.CrossRefPubMedGoogle Scholar
  40. 40.
    Fosang AJ, Last K, Knauper V, Neame PJ, Murphy G, Hardingham TE, et al. (1993) Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J 295(Pt 1):273–6.PubMedGoogle Scholar
  41. 41.
    Fuller K, Chambers TJ (1995) Localisation of mRNA for collagenase in osteocytic, bone surface and chondrocytic cells but not osteoclasts. J Cell Sci 108(Pt 6):2221–30.PubMedGoogle Scholar
  42. 42.
    Furuyama N, Fujisawa Y (2000) Distinct roles of cathepsin K and cathepsin L in osteoclastic bone resorption. Endocr Res 26:189–204.PubMedGoogle Scholar
  43. 43.
    Garnero P, Borel O, Byrjalsen I, Ferreras M, Drake FH, McQueney MS, et al. (1998) The collagenolytic activity of cathepsin K is unique among mammalian proteinases. J Biol Chem 273:32347–52.CrossRefPubMedGoogle Scholar
  44. 44.
    Gelb BD, Shi GP, Chapman HA, Desnick RJ (1996) Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 273:1236–8.PubMedGoogle Scholar
  45. 45.
    Gomis-Ruth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, et al. (1997) Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature 389:77–81.PubMedGoogle Scholar
  46. 46.
    Goto T, Kiyoshima T, Moroi R, Tsukuba T, Nishimura Y, Himeno M, et al. (1994) Localization of cathepsins B, D, and L in the rat osteoclast by immuno-light and-electron microscopy. Histochemistry 101:33–40.CrossRefPubMedGoogle Scholar
  47. 47.
    Goto T, Tsukuba T, Ayasaka N, Yamamoto K, Tanaka T (1992) Immunocytochemical localization of cathepsin D in the rat osteoclast. Histochemistry 97:13–18.CrossRefPubMedGoogle Scholar
  48. 48.
    Gowen M, Lazner F, Dodds R, Kapadia R, Feild J, Tavaria M, et al. (1999) Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization. J Bone Miner Res 14:1654–63.PubMedGoogle Scholar
  49. 49.
    Haeckel C, Krueger S, Buehling F, Broemme D, Franke K, Schuetze A, et al. (1999) Expression of cathepsin K in the human embryo and fetus. Dev Dyn 216:89–95.CrossRefPubMedGoogle Scholar
  50. 50.
    Haeckel C, Krueger S, Kuester D, Ostertag H, Samii M, Buehling F, et al. (2000) Expression of cathepsin K in chordoma. Hum Pathol 31:834–40.CrossRefPubMedGoogle Scholar
  51. 51.
    Hansen T, Unger RE, Gaumann A, Hundorf I, Maurer J, Kirkpatrick CJ, et al. (2001) Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma. Mod Pathol 14:1226–31.PubMedGoogle Scholar
  52. 52.
    Hayman AR, Cox TM (1994) Purple acid phosphatase of the human macrophage and osteoclast. Characterization, molecular properties, and crystallization of the recombinant di-iron-oxo protein secreted by baculovirus-infected insect cells. J Biol Chem 269:1294–300.PubMedGoogle Scholar
  53. 53.
    Hill PA, Buttle DJ, Jones SJ, Boyde A, Murata M, Reynolds JJ, et al. (1994) Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem 56:118–30.CrossRefPubMedGoogle Scholar
  54. 54.
    Hill PA, Murphy G, Docherty AJ, Hembry RM, Millican TA, Reynolds JJ, et al. (1994) The effects of selective inhibitors of matrix metalloproteinases (MMPs) on bone resorption and the identification of MMPs and TIMP-1 in isolated osteoclasts. J Cell Sci 107(Pt 11):3055–64.PubMedGoogle Scholar
  55. 55.
    Hollberg K, Hultenby K, Hayman A, Cox T, Andersson G (2002) Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed intracellular vesicular transport. Exp Cell Res 279:227–38.CrossRefPubMedGoogle Scholar
  56. 56.
    Holliday LS, Welgus HG, Fliszar CJ, Veith GM, Jeffrey JJ, Gluck SL (1997) Initiation of osteoclast bone resorption by interstitial collagenase. J Biol Chem 272:22053–8.CrossRefPubMedGoogle Scholar
  57. 57.
    Horton MA, Nesbit MA, Helfrich MH (1995) Interaction of osteopontin with osteoclast integrins. Ann N Y Acad Sci 760:190–200.PubMedGoogle Scholar
  58. 58.
    Hou WS, Li Z, Buttner FH, Bartnik E, Bromme D (2003) Cleavage site specificity of cathepsin K toward cartilage proteoglycans and protease complex formation. Biol Chem 384:891–7.CrossRefPubMedGoogle Scholar
  59. 59.
    Hultenby K, Reinholt FP, Heinegard D, Andersson G, Marks SC, Jr. (1995) Osteopontin: a ligand for the alpha v beta 3 integrin of the osteoclast clear zone in osteopetrotic (ia/ia) rats. Ann N Y Acad Sci 760:315–18.PubMedGoogle Scholar
  60. 60.
    Igarashi Y, Lee MY, Matsuzaki S (2002) Acid phosphatases as markers of bone metabolism. J Chromatogr B Analyt Technol Biomed Life Sci 781:345–58.PubMedGoogle Scholar
  61. 61.
    Inaoka T, Bilbe G, Ishibashi O, Tezuka K, Kumegawa M, Kokubo T (1995) Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun 206:89–96.CrossRefPubMedGoogle Scholar
  62. 62.
    Inui T, Ishibashi O, Inaoka T, Origane Y, Kumegawa M, Kokubo T, et al. (1997) Cathepsin K antisense oligodeoxynucleotide inhibits osteoclastic bone resorption. J Biol Chem 272:8109–12.CrossRefPubMedGoogle Scholar
  63. 63.
    Irie K, Tsuruga E, Sakakura Y, Muto T, Yajima T (2001) Immunohistochemical localization of membrane type 1-matrix metalloproteinase (MT1-MMP) in osteoclasts in vivo. Tissue Cell 33:478–82.PubMedGoogle Scholar
  64. 64.
    James IE, Marquis RW, Blake SM, Hwang SM, Gress CJ, Ru Y, et al. (2001) Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitro. J Biol Chem 276:11507–11.PubMedGoogle Scholar
  65. 65.
    Kafienah W, Buttle DJ, Burnett D, Hollander AP (1998) Cleavage of native type I collagen by human neutrophil elastase. Biochem J 330(Pt 2):897–902.PubMedGoogle Scholar
  66. 66.
    Karsdal MA, Fjording MS, Foged NT, Delaisse JM, Lochter A (2001) Transforming growth factor-beta-induced osteoblast elongation regulates osteoclastic bone resorption through a p38 mitogen-activated protein kinase-and matrix metalloproteinase-dependent pathway. J Biol Chem 276:39350–8.CrossRefPubMedGoogle Scholar
  67. 67.
    Khosla S (2001) Minireview: the OPG/RANKL/RANK system. Endocrinology 142:5050–5.CrossRefPubMedGoogle Scholar
  68. 68.
    Konttinen YT, Mandelin J, Li TF, Salo J, Lassus J, Liljestrom M, et al. (2002) Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. Arthritis Rheum 46:953–60.CrossRefPubMedGoogle Scholar
  69. 69.
    Kremer M, Judd J, Rifkin B, Auszmann J, Oursler MJ (1995) Estrogen Modulation of Osteoclast Lysosomal Enzyme Secretion. J Cell Biochem 57:271–79.CrossRefPubMedGoogle Scholar
  70. 70.
    Kumta SM, Huang L, Cheng YY, Chow LT, Lee KM, Zheng MH (2003) Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions. Life Sci 73:1427–36.CrossRefPubMedGoogle Scholar
  71. 71.
    Lark MW, Stroup GB, James IE, Dodds RA, Hwang SM, Blake SM, et al. (2002) A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat. Bone 30:746–53.CrossRefPubMedGoogle Scholar
  72. 72.
    Lerner UH, Grubb A (1992) Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy. J Bone Miner Res 7:433–40.PubMedGoogle Scholar
  73. 73.
    Li CY, Yam LT, Lam KW (1970) Acid phosphatase isoenzyme in human leukocytes in normal and pathologic conditions. J Histochem Cytochem 18:473–81.PubMedGoogle Scholar
  74. 74.
    Li YP, Chen W (1999) Characterization of mouse cathepsin K gene, the gene promoter, and the gene expression. J Bone Miner Res 14:487–99.PubMedGoogle Scholar
  75. 75.
    Li Z, Hou WS, Bromme D (2000) Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates. Biochemistry 39:529–36.PubMedGoogle Scholar
  76. 76.
    Li Z, Hou WS, Escalante-Torres CR, Gelb BD, Bromme D (2002) Collagenase activity of cathepsin K depends on complex formation with chondroitin sulfate. J Biol Chem 277:28669–76.PubMedGoogle Scholar
  77. 77.
    Lin SK, Kok SH, Kuo MY, Wang TJ, Wang JT, Yeh FT, et al. (2002) Sequential expressions of MMP-1, TIMP-1, IL-6, and COX-2 genes in induced periapical lesions in rats. Eur J Oral Sci 110:246–53.CrossRefPubMedGoogle Scholar
  78. 78.
    Littlewood-Evans AJ, Bilbe G, Bowler WB, Farley D, Wlodarski B, Kokubo T, et al. (1997) The osteoclastassociated protease cathepsin K is expressed in human breast carcinoma. Cancer Res 57:5386–90.PubMedGoogle Scholar
  79. 79.
    Luchin A, Suchting S, Merson T, Rosol TJ, Hume DA, Cassady AI, et al. (2001) Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation. J Biol Chem 276:36703–10.CrossRefPubMedGoogle Scholar
  80. 80.
    Martignetti JA, Aqeel AA, Sewairi WA, Boumah CE, Kambouris M, Mayouf SA, et al. (2001) Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome. Nat Genet 28:261–5.CrossRefPubMedGoogle Scholar
  81. 81.
    Migita K, Eguchi K, Tominaga M, Origuchi T, Kawabe Y, Nagataki S (1997) Beta 2-microglobulin induces stromelysin production by human synovial fibroblasts. Biochem Biophys Res Commun 239:621–5.CrossRefPubMedGoogle Scholar
  82. 82.
    Miyauchi A, Alvarez J, Greenfield EM, Teti A, Grano M, Colucci S, et al. (1993) Binding of osteopontin to the osteoclast integrin alpha v beta 3. Osteoporos Int. 3Suppl 1:132–5.PubMedGoogle Scholar
  83. 83.
    Muir P, Hayashi K, Manley PA, Colopy SA, Hao Z (2002) Evaluation of tartrate-resistant acid phosphatase and cathepsin K in ruptured cranial cruciate ligaments in dogs. Am J Vet Res 63:1279–84.PubMedGoogle Scholar
  84. 84.
    Nakase T, Takeuchi E, Sugamoto K, Kaneko M, Tomita T, Myoui A, et al. (2000) Involvement of multinucleated giant cells synthesizing cathepsin K in calcified tendinitis of the rotator cuff tendons. Rheumatology (Oxford) 39:1074–7.CrossRefPubMedGoogle Scholar
  85. 85.
    Noda M, Oh J, Takahashi R, Kondo S, Kitayama H, Takahashi C (2003) RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling. Cancer Metastasis Rev 22:167–75.CrossRefPubMedGoogle Scholar
  86. 86.
    Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, et al. (2001) The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107:789–800.CrossRefPubMedGoogle Scholar
  87. 87.
    Ohsawa Y, Nitatori T, Higuchi S, Kominami E, Uchiyama Y (1993) Lysosomal cysteine and aspartic proteinases, acid phosphatase, and an endogenous cysteine proteinase inhibitor, cystatin-beta, in rat osteoclasts. J Histochem Cytochem 41:1075–83.PubMedGoogle Scholar
  88. 88.
    Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y (1997) Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272:2446–51.PubMedGoogle Scholar
  89. 89.
    Ortega N, Behonick D, Stickens D, Werb Z (2003) How proteases regulate bone morphogenesis. Ann N Y Acad Sci 995:109–16.PubMedCrossRefGoogle Scholar
  90. 90.
    Page AE, Warburton MJ, Chambers TJ, Pringle JA, Hayman AR (1992) Human osteoclastomas contain multiple forms of cathepsin B. Biochim Biophys Acta 1116:57–66.PubMedGoogle Scholar
  91. 91.
    Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V, et al. (2000) Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med 192:789–99.CrossRefPubMedGoogle Scholar
  92. 92.
    Rantakokko J, Aro HT, Savontaus M, Vuorio E (1996) Mouse cathepsin K: cDNA cloning and predominant expression of the gene in osteoclasts, and in some hypertrophying chondrocytes during mouse development. FEBS Lett 393:307–13.CrossRefPubMedGoogle Scholar
  93. 93.
    Razzouk S, Brunn JC, Qin C, Tye CE, Goldberg HA, Butler WT (2002) Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion. Bone 30:40–7.CrossRefPubMedGoogle Scholar
  94. 94.
    Reynolds JJ (1970) Degradation processes in bone and cartilage. Calcif Tissue Res Suppl 1:52–56.Google Scholar
  95. 95.
    Rifkin BR, Vernillo AT, Kleckner AP, Auszmann JM, Rosenberg LR, Zimmerman M (1991) Cathepsin B and L activities in isolated osteoclasts. Biochem Biophys Res Commun 179:63–69.CrossRefPubMedGoogle Scholar
  96. 96.
    Ross FP, Chappel J, Alvarez JI, Sander D, Butler WT, Farach-Carson MC, et al. (1993) Interactions between the bone matrix proteins osteopontin and bone sialoprotein and the osteoclast integrin alpha v beta 3 potentiate bone resorption. J Biol Chem 268:9901–7.PubMedGoogle Scholar
  97. 97.
    Saftig P, Hunziker E, Everts V, Jones S, Boyde A, Wehmeyer O, et al. (2000) Functions of cathepsin K in bone resorption. Lessons from cathepsin K deficient mice. Adv Exp Med Biol 477:293–303.PubMedGoogle Scholar
  98. 98.
    Saftig P, Hunziker E, Wehmeyer O, Jones S, Boyde A, Rommerskirch W, et al. (1998) Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-Kdeficient mice. Proc Natl Acad Sci USA 95:13453–8.CrossRefPubMedGoogle Scholar
  99. 99.
    Sasaki T, Ueno-Matsuda E (1993) Cysteine-proteinase localization in osteoclasts: an immunocytochemical study. Cell Tissue Res 271:177–9.CrossRefPubMedGoogle Scholar
  100. 100.
    Sato T, del Carmen Ovejero M, Hou P, Heegaard AM, Kumegawa M, Foged NT, et al. (1997) Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts. J Cell Sci 110(Pt 5):589–96.PubMedGoogle Scholar
  101. 101.
    Schlondorff J, Lum L, Blobel CP (2001) Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the tumor necrosis factor alpha convertase. J Biol Chem 276:14665–74.CrossRefPubMedGoogle Scholar
  102. 102.
    Shimizu H, Sakamoto M, Sakamoto S (1990) Bone resorption by isolated osteoclasts in living versus devitalized bone: differences in mode and extent and the effects of human recombinant tissue inhibitor of metalloproteinases. J Bone Miner Res 5:411–18.PubMedCrossRefGoogle Scholar
  103. 103.
    Sodek J, Overall CM (1992) Matrix metalloproteinases in periodontal tissue remodelling. Matrix Suppl 1:352–62.PubMedGoogle Scholar
  104. 104.
    Somerville RP, Oblander SA, Apte SS (2003) Matrix metalloproteinases: old dogs with new tricks. Genome Biol 4:216.CrossRefPubMedGoogle Scholar
  105. 105.
    Stamenkovic I (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200:448–64.CrossRefPubMedGoogle Scholar
  106. 106.
    Stroup GB, Lark MW, Veber DF, Bhattacharyya A, Blake S, Dare LC, et al. (2001) Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate. J Bone Miner Res 16:1739–46.PubMedGoogle Scholar
  107. 107.
    Tepel C, Bromme D, Herzog V, Brix K (2000) Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin. J Cell Sci 113 Pt 24:4487–98.PubMedGoogle Scholar
  108. 108.
    Tezuka K, Nemoto K, Tezuka Y, Sato T, Ikeda Y, Kobori M, et al. (1994) Identification of matrix metalloproteinase 9 in rabbit osteoclasts. J Biol Chem 269:15006–9.PubMedGoogle Scholar
  109. 109.
    Tezuka K, Tezuka Y, Maejima A, Sato T, Nemoto K, Kamioka H, et al. (1994) Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts. J Biol Chem 269:1106–9.PubMedGoogle Scholar
  110. 110.
    Thompson SK, Halbert SM, Bossard MJ, Tomaszek TA, Levy MA, Zhao B, et al. (1997) Design of potent and selective human cathepsin K inhibitors that span the active site. Proc Natl Acad Sci USA 94:14249–54.PubMedGoogle Scholar
  111. 111.
    Uppenberg J, Lindqvist F, Svensson C, Ek-Rylander B, Andersson G (1999) Crystal structure of a mammalian purple acid phosphatase. J Mol Biol 290:201–11.CrossRefPubMedGoogle Scholar
  112. 112.
    Vaes G (1988) Cellular biology and biochemical mechanism of bone resorption. A review of recent developments on the formation, activation, and mode of action of osteoclasts. Clin Orthop 239–71.Google Scholar
  113. 113.
    Vaes G, Delaisse JM, Eeckhout Y (1992) Relative roles of collagenase and lysosomal cysteine-proteinases in bone resorption. Matrix Suppl 1:383–8.PubMedGoogle Scholar
  114. 114.
    Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, et al. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411–22.CrossRefPubMedGoogle Scholar
  115. 115.
    Walsh NC, Cahill M, Carninci P, Kawai J, Okazaki Y, Hayashizaki Y, et al. (2003) Multiple tissue-specific promoters control expression of the murine tartrate-resistant acid phosphatase gene. Gene 307:111–23.CrossRefPubMedGoogle Scholar
  116. 116.
    Wilhelm SM, Collier IE, Kronberger A, Eisen AZ, Marmer BL, Grant GA, et al. (1987) Human skin fibroblast stromelysin: structure, glycosylation, substrate specificity, and differential expression in normal and tumorigenic cells. Proc Natl Acad Sci USA 84:6725–9.PubMedGoogle Scholar
  117. 117.
    Yamashita DS, Dodds RA (2000) Cathepsin K and the design of inhibitors of cathepsin K. Curr Pharm Des 6:1–24.CrossRefPubMedGoogle Scholar
  118. 118.
    Zaidi M, Troen B, Moonga BS, Abe E (2001) Cathepsin K, osteoclastic resorption, and osteoporosis therapy. J Bone Miner Res 16:1747–9.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2005

Authors and Affiliations

  • Merry Jo Oursler

There are no affiliations available

Personalised recommendations